NYSE:CORHealthcare
Cencora Expands Into Retina Care With EyeSouth Deal And EPS Focus
Cencora (NYSE: COR) has agreed to acquire EyeSouth’s retina business, expanding its footprint in specialty retina services.
The transaction is expected to be accretive to adjusted earnings per share within a year of closing.
The deal signals a deeper push into higher acuity eye care services and related distribution capabilities.
Cencora enters this transaction with its shares at $308.19, after a 1-year return of 8.6% and a 3-year return of 89.6%. Over 5 years, the return stands at 169.0%,...